Press Releases | Medtronic

Month Year

Email alerts

Oct 13, 2015

Medtronic CoreValve® System Shows Positive Clinical Outcomes in New Patient Populations

New Data Show Low Mortality and Improved Quality of Life for Patients with Failed Surgical Aortic Valves, End-Stage Renal Disease and Low Gradient Aortic Stenosis

DUBLIN and SAN FRANCISCO - October 13, 2015 - Medtronic plc (NYSE: MDT) today unveiled new clinical data that showed positive clinical outcomes at one year for the CoreValve System in new patient...
Sep 14, 2015

Medtronic First to Receive FDA Approval for MR-Conditional Implantable Cardioverter Defibrillator System

Evera MRI ICD System Approved for Use During Full Body MRI Scans for Patients at Risk of Sudden Cardiac Arrest

DUBLIN - Sept. 14, 2015 - Medtronic plc (NYSE: MDT) today announced that it has received the first U.S. Food and Drug Administration (FDA) approval for an implantable cardioverter defibrillator...
May 18, 2015

Data Show Medtronic Quadripolar CRT Technology Optimizes Treatment for Heart Failure Patients

Positive Results from Two Studies Featured at Heart Rhythm Society 36th Annual Scientific Sessions

DUBLIN and BOSTON - MAY 18, 2015 -Medtronic plc (NYSE: MDT) today announced study results demonstrating that its quadripolar cardiac resynchronization therapy (CRT) system gives physicians more...
May 12, 2015

Medtronic Receives FDA Approval and CE Mark for Arctic Front Advance® ST Cryoballoon to Treat Atrial Fibrillation

Third-Generation Cryoballoon Designed to Allow Enhanced Positioning and Help Improve Capture of Real-Time Data with Achieve® Mapping Catheter

DUBLIN - May 12, 2015 - Medtronic plc (NYSE: MDT) today announced the Arctic Front Advance® ST Cryoablation Catheter has received U.S. Food and Drug Administration (FDA) approval for the...
May 7, 2015

Medtronic Initiates Study Of ‘In-Office’ Insertion Of Reveal LINQ™ Cardiac Monitor

RIO 2 Study Evaluates Safety and Effectiveness of Moving the Insertion Procedure from Hospital to Office Setting

DUBLIN – May 7, 2015 – Medtronic plc (NYSE: MDT) today announced the first inoffice implant of its miniaturized cardiac monitor as part of the Medtronic Reveal LINQ In-Office 2 (RIO 2) Study....
Feb 19, 2015

Medicare Approves Transitional Pass-Through Payment for Outpatient Use of Medtronic Drug-Coated Balloon

CMS Decision Provides Supplemental Reimbursement to U.S. Hospitals for New Medical Device with Potential to Improve Standard of Care for Peripheral Arterial Disease in Upper Leg

DUBLIN - Feb. 19, 2015 - Medtronic plc (NYSE: MDT) announced today that the U.S. Centers for Medicare and Medicaid Services (CMS) has approved a transitional pass-through payment for the company's...
Feb 11, 2015

Medtronic Insertable Cardiac Monitors Detect Atrial Fibrillation In Stroke Patients In ‘Real – World’ Study

Findings Reinforce Patient Benefit of Reveal LINQ in Real-World Setting

DUBLIN and NASHVILLE – Feb. 11, 2015 – Medtronic plc (NYSE: MDT), today announced the results of a new “real-world” study of patients who have had a cryptogenic stroke (stroke of unknown...
Feb 4, 2015

Medtronic Starts U.S. Launch Of IN.PACT Admiral Drug-Coated Balloon For Treatment Of Peripheral arterial Disease In Upper Leg

First Uses of New Medical Device Following FDA Approval Take Place at Hospitals Nationwide

DUBLIN – Feb. 4, 2015 – U.S. hospitals this week began using a new medical device from Medtronic plc (NYSE: MDT) called the IN.PACT Admiral drug-coated balloon (DCB) to treat patients with...
Jan 29, 2015

Studies Show Benefits of Medtronic SmartShock(TM) Technology and Physician Reports in Protecting Patients from Inappropriate Shocks

New Results from PainFree SST, Shock-Less Studies, Involving Nearly 7,000 Patients, Published in HeartRhythm

DUBLIN and MINNEAPOLIS - Jan. 29, 2015 - Medtronic plc (NYSE: MDT) today announced new results from the PainFree SST and Shock-Less clinical studies published in the journal HeartRhythm. The data...
Jan 5, 2015

Medtronic Drug-Coated Balloon Receives FDA Approval for Treating Peripheral Artery Disease in Upper Leg

Pivotal Study Shows New Medical Device Provides Exceptional Clinical Outcomes and Reduces Need for Costly Repeat Procedures

MINNEAPOLIS -- Jan. 5, 2015 -- Medtronic, Inc. (NYSE: MDT) announced today that the U.S. Food and Drug Administration (FDA) has approved the company's IN.PACT Admiral drug-coated balloon (DCB) for...

Show per page